AAPS presents Dale E. Wurster award to Stephen Byrn for his work in the field of solid state chemistry.
Stephen R. Byrn of Purdue University was named the recipient of the 2016 Dale E. Wurster Award for his work in the field of solid state chemistry of drugs from the American Association of Pharmaceutical Scientists (AAPS). The award was announced on Nov. 13, 2016, at the AAPS annual meeting in Denver, CO.
Bryn is credited with setting in motion the development of solid state chemistry of drugs with books and papers on the subject, the first of which were published in the mid-1970s. He has taught more than 100 short courses and has educated more than 50 doctorate students. He is cofounder of Purdue’s regulatory graduate programs and the Purdue-Kilimanjaro Sustainable Medicines in Africa Program. He has chaired several FDA and USP committees, is involved in The National Institute for Pharmaceutical Technology and Education, and is cofounder of SSCI, Inc.
Supported by the Dale E. Wurster Endowment, this award is given to individuals who have made significant contributions to the pharmaceutical sciences in the specific field of pharmaceutics.
Source: American Association of Pharmaceutical Scientists
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.